A new tagging system for production of recombinant proteins in Drosophila S2 cells using the third domain of the urokinase receptor

Protein Expression and Purification

Volumn 52, Issue 2, 2007, Pages 384-394

  Gårdsvoll, Henrik ^a   Hansen, Line V ^a   Jørgensen, Thomas J D ^b   Ploug, Michael ^a  

^a FINSEN LABORATORY   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

C4.4A; CD59; Drosophila S2 cells; Fusion protein; Immunoaffinity chromatography; Recombinant protein expression; Urokinase receptor; Vitronectin

Indexed keywords

CELL SURFACE RECEPTOR; PLASMINOGEN ACTIVATOR, UROKINASE RECEPTORS; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CELL CULTURE; CYTOLOGY; DROSOPHILA; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

ANIMALS; CELLS, CULTURED; DROSOPHILA; GENE EXPRESSION; HUMANS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS;

EID: 33846419101     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2006.11.013     Document Type: Article

References (35)

1. Fritze C.E., and Andersen T.R. Epitope tagging: general method for tracking recombinant proteins. Methods Enzymol. 327 (2000) 3-16
2. Terpe K. Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems. Appl. Microbiol. Biotechnol. 60 (2003) 523-533
3. Gårdsvoll H., Danø K., and Ploug M. Mapping part of the functional epitope for ligand binding on the human receptor for urokinase-type plasminogen activator by site-directed mutagenesis. J. Biol. Chem. 274 (1999) 37995-38003
4. Ploug M., Østergård S., Gårdsvoll H., Holm A., Holst-Hansen C., Ossowski L., and Danø K. Peptid derived antagonists of the urokinase receptor. Affinity maturation by combinatorial chemistry, identification of functional epitopes, and inhibitory effect on cancer cell intravasation. Biochemistry 40 (2001) 12157-12168
5. Gårdsvoll H., Werner F., Søndergaard L., Danø K., and Ploug M. Characterization of low-glycosylated forms of soluble human urokinase receptor expressed in Drosophila Schneider 2 cells after deletion of glycosylation-sites. Protein Expr. Purif. 34 (2004) 284-295
6. Gårdsvoll H., Guilguin B., Le Du M.H., Menez A., Jørgensen T.J.D., and Ploug M. Characterization of the functional epitope on uPAR for uPA. Complete alanine scanning mutagenesis of uPAR supplemented by chemical crosslinking. J. Biol. Chem. 281 (2006) 19260-19272
7. Ploug M., and Ellis V. Structure-function relationships in the receptor for urokinase-type plasminogen activator Comparison to other members of the Ly-6 family and snake venom α-neurotoxins. FEBS Lett. 349 (1994) 163-168
8. Maio M., Brasoveanu L.I., Coral S., Sigalotti L., Lamaj E., Gasparollo A., Visintin A., Altomonte M., and Fonsatti E. Structure, distribution, and functional role of protectin (CD59) in complement-susceptibility and in immunotherapy of human malignancies. Int. J. Oncol. 13 (1998) 305-318
9. Hansen L., Gårdsvoll H., Nielsen B.S., Lund L.R., Danø K., Jensen O.N., and Ploug M. Structural analysis and tissue localization of human C4.4A: a protein homoloque of the urokinase receptor. Biochem. J. 380 (2004) 845-857
10. Schvartz I., Seger D., and Shaltiel S. Vitronectin. Int. J. Biochem. Cell Biol. 31 (1999) 539-544
11. Okada H., Nagami Y., Takahashi K., Okada N., Hideshima T., Takizawa H., and Kondo J. 20 KDa homologous restriction factor of complement resembles T cell activating protein. Biochem. Biophys. Res. Commun. 162 (1989) 1553-1559
12. Würfel J., Seiter S., Stassar M., Claas A., Klas R., Rosel M., Marhaba R., Savelyeva L., Schwab M., Matzku S., and Zöller M. Cloning of the human homologue of the metastasis-associated rat C4.4A. Gene 262 (2001) 35-41
13. Solem M., Helmrich A., Collodi P., and Barnes D. Human and mouse S-protein mRNA detected in northern blot experiments and evidence for the gene encoding S-protein in mammals by Southern blot analysis. Mol. Cell. Biochem. 100 (1991) 141-149
14. Rønne E., Behrendt N., Ploug M., Nielsen H.J., Wollisch E., Weidle E.U., Danø K., and Høyer-Hansen G. Quantitation of the receptor for urokinase plasminogen activator by enzyme-linked immunosorbent assay. J. Immunol. Methods 167 (1991) 91-101
15. Xu D., Baburaj K., Peterson C.B., and Xu Y. Model for the three-dimensional structure of vitronectin: Predictions for the multi-domain protein from threading and docking. Proteins 44 (2001) 312-320
16. Roldan A.L., Cubellis M.V., Masucci M.T., Behrendt N., Lund L.R., Danø K., Appella E., and Blasi F. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J. 9 (1990) 467-474
17. Picard V., Ersdal-Badju E., Lu A., and Bock S. A rapid and efficient one-tube PCR-based mutagenesis technique using Pfu DNA polymerase. Nucleic Acids Res. 22 (1994) 2587-2591
18. Rønne E., Høyer-Hansen G., Brünner N., Pedersen H., Rank F., Osborne C.K., Clark G.M., Danø K., and Grøndahl-Hansen J. Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies. Breast Cancer Res. Treat. 33 (1995) 199-207
19. Ploug M., Rahbek-Nielsen H., Nielsen P.F., Roepstorff P., and Danø K. Glycosylation profile of a recombinant urokinase receptor expressed in Chinese hamster ovary cells. J. Biol. Chem. 273 (1998) 13933-13943
20. Llinas P., Le Du M.H., Gårdsvoll H., Danø K., Ploug M., Gilquin B., Stura E.A., and Menez A. Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide. EMBO J. 24 (2005) 1655-1663
21. Lynn G.W., Heller W.T., Mayasundari A., Minor K.H., and Peterson C.B. A model for the three-dimensional structure of human plasma vitronectin from small-angle scattering measurements. Biochemistry 44 (2005) 565-574
22. Wojciechowski K.M., Chang C.H., and Hocking D.C. Expression, production, and characterization of full-length vitronectin in Esccherichia coli. Protein Expr. Purif. 36 (2004) 131-138
23. Hammerström M., Woestenenk E.A., Hellgren N., Härd T., and Berglund H. Effect of N-terminal solubility enhancing fusion proteins on yield of purified target protein. J. Struct. Funct. Genom. (2006) July 19, electronic
24. Ploug M. Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor. Curr. Pharm. Des. 9 (2003) 1499-1528
25. Ploug M., Ellis V., and Danø K. Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate. Evidence for a hydrophobic binding site exposed only on the intact receptor. Biochemistry 33 (1994) 8991-8997
26. Høyer-Hansen G., Behrendt N., Ploug M., Danø K., and Preissner K.T. The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction. FEBS Lett. 420 (1997) 79-85
27. 2+-ATPase. Protein Expr. Purif. 36 (2004) 31-39
28. Wang A., Clapper J., Guderian J.A., Foy T.M., Fanger G.R., Retter M.W., and Skeiky Y.A.W. A novel method for increasing the expression level of recombinant proteins. Protein Expr. Purif. 30 (2003) 124-133
29. 4Lys on Enterokinase cleavage of a fusion protein. Anal. Biochem. 269 (1999) 10-16
30. Huber W., Perspicace S., Kohler J., Müller F., and Schlatter D. SPR-based interaction studies with small molecular weight ligands using hAGT fusion protein. Anal. Biochem. 333 (2004) 280-288
31. Lichty J.J., Malecki J.L., Agnew H.D., Michelson-Horowitz D.J., and Tan S. Comparison of affinity tags for purification. Protein Expr. Purif. 41 (2005) 98-105
32. Rønne E., Behrendt N., Ploug M., Nielsen H.J., Wollisch E., Weidle U., Danø K., and Høyer-Hansen G. Quantitation of the receptor for urokinase plasminogen activator by enzyme-linked immunosorbent assay. J. Immunol. Methods 167 (1994) 91-101
33. Masucci M.T., Pedersen N., and Blasi F. A soluble, ligand binding mutant of the human urokinase plasminogen activator receptor. J. Biol. Chem. 266 (1991) 8655-8658
34. Fazioli F., Resnati M., Sidenius N., Higashimoto Y., Appella E., and Blasi F. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. EMBO J. 16 (1997) 7279-7286
35. Wei Y., Waltz D.A., Rao N., Drummond R.J., Rosenberg S., and Chapman H.A. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. (1994) 32380-32388